-
Socio-Economic and Behavioural Impacts of COVID-19 Vaccine Mandates: A Scoping Review
Mar 10, 2025, 14:00 PM -
Impact of Adverse Event Definitions on Real-World Detection of Oncology Immune-Related Adverse Events
Mar 10, 2025, 14:00 PM -
Real-World Health-Related Quality of Life and Treatment Satisfaction in Patients With High-Risk Non-Muscle Invasive Bladder Cancer
Mar 10, 2025, 14:00 PM -
Comparing the Social and Private Value Created by Pembrolizumab 2014-2022
Mar 10, 2025, 14:00 PM -
Beyond Overall Survival: Advancing the Understanding and Use of Surrogate Endpoints in Oncology
Mar 10, 2025, 14:00 PM -
Exploring Mobile and Wearable Technology for Early Depression Detection and Monitoring
Mar 10, 2025, 14:00 PM -
Real-World Demographic and Clinical Characteristics of Patients With Atherosclerotic Cardiovascular Disease With or Without Chronic Kidney Disease or Systemic Inflammation in the United States
Mar 10, 2025, 14:00 PM -
Perspectives on Real-World Management of Stomatitis/Oral Mucositis (S/OM) From Oncologists With Experience Treating Patients With Metastatic Non-Small Cell Lung Cancer (mNSCLC) and Metastatic Breast Cancer (mBC)
Mar 10, 2025, 14:00 PM -
Cost Per PFS-Based Responder for TKI-Naive Patients Receiving Repotrectinib or Entrectinib in ROS1 Fusion Positive Non-Small Cell Lung Cancer (NSCLC) in the United States (US)
Mar 10, 2025, 14:00 PM -
Methods for Handling Non-Proportional Hazards in Economic Modeling
Mar 10, 2025, 14:00 PM -
Methodological Variations in Systematic Reviews of Health Economic Models
Mar 10, 2025, 14:00 PM -
Concordance of ER and HER2 Status by Claims-Based Algorithm and Large Language Models (LLM) Abstracted Clinical Notes in Patients With Metastatic Breast Cancer (mBC)
Mar 10, 2025, 14:00 PM -
PROM-ising Progress? Patient-Reported Outcome Measures in Orphan Labels
Mar 10, 2025, 14:00 PM -
Estimating the Magnitude of a Pull Incentive for Antibiotic Development Using the STEDI Value Framework: An Example From Spain
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Follitropin Delta versus Follitropin Alfa in Controlled Ovarian Stimulation for IVF/ICSI Cycles in China
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization Among Ticagrelor-Treated Patients With Bleeding or Undergoing Urgent Surgery in the United States: A Real-World, Retrospective Claims Analysis
Mar 10, 2025, 14:00 PM -
Real-World Adverse Event Profile of Glucagon-Like Peptide-1 Receptor Agonists in Overweight and Obese US Adults
Mar 10, 2025, 14:00 PM -
An Open-Source R-Shiny Application Designed to Perform Frequentist and Bayesian Mixed Model Repeated Measures (MMRM)
Mar 10, 2025, 14:00 PM -
The Efficacy of Panitumumab Plus Chemotherapy As Initial Treatment for KRAS Wild-Type Unresectable, Metastatic Colorectal Cancer: A GRADE-Approach Systematic Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Acute Myocardial Infarction and Associated Healthcare Resource Utilization and Costs Among U.S. Patients With Extreme High Versus Low Lipoprotein (a)
Mar 10, 2025, 14:00 PM